CIO Influence
CIO Influence News Networking Security

Nord Security Extends Its Portfolio of Cybersecurity Brands With Atlas VPN

Nord Security Extends Its Portfolio of Cybersecurity Brands With Atlas VPN

Nord Security, one of the leaders in the cybersecurity market, has reached a deal to incorporate Atlas VPN. This move will further extend Nord Security’s portfolio of cybersecurity brands and solidify its spot as the premier company for all things cybersecurity.

Atlas VPN is a “freemium” VPN solution that ensures private browsing by changing the IP address and encrypting connections. Established in 2019, Atlas VPN has already made great strides in the cybersecurity sector and has a growing reach and position in the developing markets.

PREDICTIONS SERIES 2022

Top iTechnology Networking News: VVDN Gets Approval Under PLI Scheme for Telecom and Networking Equipment

Nord Security has extensive knowledge in building advanced cybersecurity solutions. Its portfolio consists of brands like NordVPN, NordPass, NordLayer, NordLocker, and NordWL. Nord products are acknowledged by the most influential IT security specialists and tech sites.

Atlas VPN will become a part of Nord Security’s corporate structure and will be required to adhere to the core principles of transparency and trustworthiness set by Nord brands, including regular third-party audits. However, on a daily basis, the team behind Atlas VPN will continue to act independently and pursue their goals in the “freemium” segment.

Details of the transaction are not disclosed as both companies are privately owned entities.

Top iTechnology Networking News: Owl Announces LBSA Certification for Industry’s only VoIP and Full-Motion Video Cross Domain Solutions

[To share your insights with us, please write to sghosh@martechseries.com]

Related posts

Ransomware Vulnerabilities Spike by 7.6% in Q1 2022

Dynatrace Launches New Kubernetes Experience for Platform Engineering Teams

Business Wire

How Harmonized Scientific Data in the Cloud Will Fuel the Next Evolution of Drug Discovery

CIO Influence News Desk

Leave a Comment